Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000796501 | SCV000936019 | likely benign | Tuberous sclerosis 1 | 2023-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003344053 | SCV004066702 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-08-30 | criteria provided, single submitter | clinical testing | The p.R228Q variant (also known as c.683G>A), located in coding exon 6 of the TSC1 gene, results from a G to A substitution at nucleotide position 683. The arginine at codon 228 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
All of Us Research Program, |
RCV004001600 | SCV004825037 | uncertain significance | Tuberous sclerosis syndrome | 2023-08-15 | criteria provided, single submitter | clinical testing |